Gold Member Since 2012
Audited Supplier
Wuhan Lianshangwang Technology Co., Ltd.

Goserelin, 145781-92-6, Anti-Cancer manufacturer / supplier in China, offering Goserelin Acetate White Powder CAS: 145781-92-6 for Treating Breast Cancer, No Side Effect Deca Powder Nandrolone Decanoate 360-70-3, Pharmaceutical Steroids, Safety Trenbolone Enanthate Steroid Trenbolone Acetate with Sustanon 250 and so on.

(/ )

Supplier Homepage Product Pharmaceutical Intermediates Others Pharmaceutical Intermediates Goserelin Acetate White Powder CAS: 145781-92-6 for Treating Breast Cancer

Goserelin Acetate White Powder CAS: 145781-92-6 for Treating Breast Cancer

Purchase Qty.:
10-99 100+
FOB Unit Price: US $5 US $3
Purchase Qty. (g) FOB Unit Price
10-99 US $5
100+ US $3
Get Latest Price
Port: Hong Kong, Hong Kong
Production Capacity: 5000kg/Month
Payment Terms: T/T, Western Union, Money Gram, Bitcoin
Basic Info
  • Model NO.: 145781-92-6
  • Customized: Non-Customized
  • Suitable for: Adult
  • Purity: >99%
  • MW: 1269.41
  • Transport Package: Discreet Package
  • Origin: China
  • Powder: Yes
  • Certification: GMP, ISO 9001, USP
  • State: Solid
  • Mf: C59h84n18o14
  • Trademark: LSW
  • Specification: USP, BP
  • HS Code: 2906131000
Product Description

Goserelin acetate White Powder CAS: 145781-92-6 for Treating Breast Cancer


Goserelin (INN, USAN, BAN) (brand name Zoladex, by AstraZeneca), or goserelin acetate,is a drug used to suppress production of the sex hormones (testosterone and estrogen), particularly in the treatment of breast and prostate cancer. It is an injectable gonadotropin releasing hormone superagonist (GnRH agonist), also known as a luteinizing hormone releasing hormone (LHRH) agonist.


Product name
Goserelin acetate
145781-92-6Outer Packing
Production date
161221Shelf life
2 years
Standard adopted
Items of analysis
AppearanceWhite or almost white powderConforms
SolubilitySoluble in water,freely soluble in glacial acetic acid.It dissolves Conforms
PurityNLT 97.5%99.4%


Goserelin acetate stimulates the production of the sex hormones testosterone and estrogen in a non-pulsatile (non-physiological) manner. This causes the disruption of the endogenous hormonal feedback systems, resulting in the down-regulation of testosterone and estrogen production.

Zoladex was approved by the U.S. Food and Drug Administration in 1989 for treatment of prostate cancer.

Indications and Usage:


Palliative treatment of advanced carcinoma of the prostate; in combination with flutamide for management of locally confined stage T2b to T4 (stage B2 to C) carcinoma of the prostate.

Women (3.6 mg only)

Palliative treatment of advanced breast cancer in pre- and perimenopausal women; treatment of endometriosis; as an endometrial thinning agent prior to endometrial ablation for dysfunctional uterine bleeding.


Known hypersensitivity to GnRH, GnRH agonist analogues, or any of the components in goserelin; pregnancy unless goserelin is being used for palliative treatment of advanced breast cancer.

Mechanism of Action:

Goserelin acetate is an anti-cancer drug, classified as an analog of naturally occurring luteinizing hormone-releasing hormone (LHRH), and it is used for the treatment of prostate cancer, breast cancer, endometriosis, and abnormal bleeding of the uterus. "The acetate salt of a synthetic decapeptide analog of luteinizing hormone-releasing hormone (LHRH). Continuous, prolonged administration of goserelin in males results in inhibition of pituitary gonadotropin secretion, leading to a significant decline in testosterone production; in females, prolonged administration results in a decrease in estradiol production," note the National Cancer Institute (NCI) Drug Dictionary.

Both breast and prostate cancer are the second most common types of cancer among women and men respectively, and its growth is often promoted by sex hormones. Therefore, the mechanism of action of goserelin acetate is based on interfering with these hormones to decrease their amount in the body and stop cancer growth. Goserelin acetate is available as an implant that is inserted by a doctor or nurse with a syringe subcutaneously in the area of the stomach. Depending on the patient's needs and disease, the implant can have 3.6 mg of goserelin inserted every four weeks or 10.8 mg of goserelin to be implanted every 12 weeks. The length of the treatment also depends on the condition being treated and patient's response to the medication.

Goserelin Acetate White Powder CAS: 145781-92-6 for Treating Breast Cancer

Our Advantages:

1. Good reputation:
Our company is a leading chemical company in China, and has more than 16 years history. We have over 10 branch offices, all enjoy good reputation from worldwide customers.

2. High Quality&low price
All of our products have top quality and high purity, since we are the factory, our price is competitive.

3. Multiple payment methods.
We have mutiple payment methods, T/T, Western Unoin, MoneyGram, and Bitcoin for your convenience.

4. Mass Stock
In order to better serve our customers, we are preparing mass stock in our warehouse, we can always ship your parcel within 24 hours.

5. High customs clearance pass rate.
Through 16 years hard work, we have accumulated rich exporting experience to USA, UK, France, Italy, Germany,Spain, Brail, korea, India and so on.We will use special ways to disguise the goods, 98% customs clearance rate is guaranteed, if the delivery is not successful, we will resend for free.

6. Warm After service.
If you have any problems about the goods, do no hesitate to contact us, we can provide 7/24 service.

Tel: +8618872220738
Send your message to this supplier
Mr. Ken
Market Director
To: Mr. Ken

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category